SEC Filing Summary: Atlantic Technology Ventures, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by Atlantic Technology Ventures, Inc. on May 15, 2001, covering an event that occurred on May 4, 2001. The registrant is a Delaware corporation headquartered in New York. Note: The input metadata references "TG THERAPEUTICS, INC.", but the filing text explicitly identifies the registrant as "ATLANTIC TECHNOLOGY VENTURES, INC."
Key Financial Metrics
The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for this reporting period. The document focuses exclusively on a specific asset transaction.
Material Changes
On May 4, 2001, Atlantic Technology Ventures, Inc. completed the sale of substantially all assets of Gemini Technologies, Inc., an 85%-owned subsidiary. The assets were sold to IFN, Inc., an affiliate of the Cleveland Clinic Foundation. The transaction was executed pursuant to an asset purchase agreement dated April 23, 2001.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future outlook, or specific risk factors related to this transaction. For further details regarding the transaction, the registrant refers investors to its Quarterly Report on Form 10-QSB for the period ended March 31, 2001.
Key Facts for Investor Verification
- Verify the exact consideration received for the sale of Gemini Technologies, Inc. assets, as this figure is not disclosed in the 8-K.
- Review the Form 10-QSB for the quarter ended March 31, 2001, for detailed financial impact and transaction terms.
- Confirm the remaining ownership structure of Atlantic Technology Ventures, Inc. following the divestiture of the 85%-owned subsidiary.
- Clarify the discrepancy between the metadata company name ("TG THERAPEUTICS, INC.") and the filing registrant ("ATLANTIC TECHNOLOGY VENTURES, INC.").